The APC gene product in normal and tumor cells

K J Smith, K A Johnson, T M Bryan, D E Hill, S Markowitz, J K Willson, C Paraskeva, G M Petersen, S R Hamilton, B Vogelstein, K J Smith, K A Johnson, T M Bryan, D E Hill, S Markowitz, J K Willson, C Paraskeva, G M Petersen, S R Hamilton, B Vogelstein

Abstract

The APC gene has been found to be mutated during the development of sporadic colorectal tumors as well as in the germ line of familial adenomatous polyposis patients. To facilitate the characterization of both normal and mutant APC protein, a series of monoclonal and polyclonal antibodies specific for the APC protein was produced. When lymphoblastoid cell lines derived from seven familial adenomatous polyposis patients with known mutations were analyzed by Western blot, an approximately 300-kDa protein corresponding to the predicted size of full-length APC was detected in all 7 cell lines. In addition, truncated APC proteins corresponding to the product of the known mutated alleles could be detected in 4 of the 7 lines. Similar analysis of 23 colon carcinoma and 9 adenoma cell lines revealed truncated proteins in 24 (75%) of the cell lines. Moreover, 26 (81%) of the colon tumor lines were totally devoid of the normal, full-length protein. In contrast, Western blot analysis of 40 cell lines derived from sporadic tumors of other organs detected only full-length APC. Immunohistochemical analysis of APC in normal colonic mucosa revealed cytoplasmic staining with more intense staining in the basolateral margins of the epithelial cell. This staining was markedly increased in the upper portions of the crypts, suggesting an increased level of expression with maturation. These studies provide some initial clues to the function of the cytoplasmic protein APC and demonstrate the feasibility of identifying APC mutations by direct analysis of the APC protein.

References

    1. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4452-6
    1. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3385-8
    1. Nature. 1992 Sep 17;359(6392):235-7
    1. Int J Cancer. 1992 Nov 11;52(5):785-90
    1. Hum Mol Genet. 1992 Jul;1(4):229-33
    1. Cancer Res. 1976 Dec;36(12):4562-9
    1. Int J Cancer. 1984 Jul 15;34(1):49-56
    1. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6779-83
    1. Cancer Res. 1984 Dec;44(12 Pt 1):5813-21
    1. Cancer Res. 1987 May 15;47(10):2704-13
    1. Anal Biochem. 1987 Oct;166(1):49-54
    1. Gene. 1988 Jul 15;67(1):31-40
    1. Cancer Res. 1989 Mar 1;49(5):1282-6
    1. Oncogene. 1989 May;4(5):543-8
    1. Mol Cell Biol. 1989 Nov;9(11):4596-604
    1. Methods Enzymol. 1991;194:477-90
    1. Science. 1991 Jul 5;253(5015):49-53
    1. Anal Biochem. 1991 May 1;194(2):407-12
    1. Cell. 1991 Aug 9;66(3):589-600
    1. Cell. 1991 Aug 9;66(3):601-13
    1. Science. 1991 Aug 9;253(5020):661-5
    1. Science. 1991 Aug 9;253(5020):665-9
    1. Oncogene. 1991 Oct;6(10):1881-6
    1. Mol Cell Biol. 1992 Mar;12(3):1149-61
    1. Cancer Res. 1992 Apr 1;52(7):1996-9
    1. Nature. 1992 Jul 2;358(6381):80-3

Source: PubMed

3
Abonnieren